These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 19889449

  • 1. NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide.
    Minig L, Trimble EL, Birrer MJ, Kim KY, Takebe N, Abrams JS.
    Gynecol Oncol; 2010 Feb; 116(2):177-80. PubMed ID: 19889449
    [Abstract] [Full Text] [Related]

  • 2. The NCI All Ireland Cancer Conference.
    Johnston PG, Daly PA, Liu E.
    Oncologist; 1999 Feb; 4(4):275-277. PubMed ID: 10545862
    [Abstract] [Full Text] [Related]

  • 3. Impact of the National Cancer Act on grant support.
    Kalberer JT.
    Cancer Res; 1975 Mar; 35(3):472-81. PubMed ID: 1090361
    [Abstract] [Full Text] [Related]

  • 4. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
    Christian MC, Pluda JM, Ho PT, Arbuck SG, Murgo AJ, Sausville EA.
    Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CAM evaluation comes into the mainstream: NIH specialized Centers of research and the University of Maryland Center for Alternative Medicine Research in Arthritis.
    Berman BM, Hartnoll S, Bausell B.
    Complement Ther Med; 2000 Jun; 8(2):119-22. PubMed ID: 10859605
    [Abstract] [Full Text] [Related]

  • 8. Concerning trends and outcomes for National Institutes of Health funding of cancer research.
    Bland KI.
    J Surg Oncol; 2007 Feb 01; 95(2):161-6. PubMed ID: 17262723
    [Abstract] [Full Text] [Related]

  • 9. Complementary and alternative medicine research: a National Cancer Institute perspective.
    White JD.
    Semin Oncol; 2002 Dec 01; 29(6):546-51. PubMed ID: 12516037
    [Abstract] [Full Text] [Related]

  • 10. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR, White JD, O'Mara AM, Kelaghan JW, Smith WB, Minasian LM.
    J Clin Oncol; 2005 Sep 20; 23(27):6682-9. PubMed ID: 16170176
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.